174 related articles for article (PubMed ID: 27766457)
1. Decreased urinary excretion of the ectodomain form of megalin (A-megalin) in children with OCRL gene mutations.
Suruda C; Tsuji S; Yamanouchi S; Kimata T; Huan NT; Kurosawa H; Hirayama Y; Tsukaguchi H; Saito A; Kaneko K
Pediatr Nephrol; 2017 Apr; 32(4):621-625. PubMed ID: 27766457
[TBL] [Abstract][Full Text] [Related]
2. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
[TBL] [Abstract][Full Text] [Related]
3. Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model.
Gliozzi ML; Espiritu EB; Shipman KE; Rbaibi Y; Long KR; Roy N; Duncan AW; Lazzara MJ; Hukriede NA; Baty CJ; Weisz OA
J Am Soc Nephrol; 2020 Jan; 31(1):67-83. PubMed ID: 31676724
[TBL] [Abstract][Full Text] [Related]
4. Kidney Tubular Ablation of
Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S
J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory features of Macedonian children with OCRL mutations.
Tasic V; Lozanovski VJ; Korneti P; Ristoska-Bojkovska N; Sabolic-Avramovska V; Gucev Z; Ludwig M
Pediatr Nephrol; 2011 Apr; 26(4):557-62. PubMed ID: 21249396
[TBL] [Abstract][Full Text] [Related]
6. A case of Dent disease type 2 with large deletion of OCRL diagnosed after close examination of a school urinary test.
Motoyoshi Y; Yabuuchi T; Miura K; Hattori M; Kiyohara K
CEN Case Rep; 2022 Aug; 11(3):366-370. PubMed ID: 35098431
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel OCRL isoforms associated with phenotypic differences between Dent disease-2 and Lowe syndrome.
Sakakibara N; Ijuin T; Horinouchi T; Yamamura T; Nagano C; Okada E; Ishiko S; Aoto Y; Rossanti R; Ninchoji T; Awano H; Nagase H; Minamikawa S; Tanaka R; Matsuyama T; Nagatani K; Kamei K; Jinnouchi K; Ohtsuka Y; Oka M; Araki Y; Tanaka T; Harada MS; Igarashi T; Kitahara H; Morisada N; Nakamura SI; Okada T; Iijima K; Nozu K
Nephrol Dial Transplant; 2022 Jan; 37(2):262-270. PubMed ID: 34586410
[TBL] [Abstract][Full Text] [Related]
8. Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.
Bothwell SP; Chan E; Bernardini IM; Kuo YM; Gahl WA; Nussbaum RL
J Am Soc Nephrol; 2011 Mar; 22(3):443-8. PubMed ID: 21183592
[TBL] [Abstract][Full Text] [Related]
9. Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.
Bockenhauer D; Bokenkamp A; van't Hoff W; Levtchenko E; Kist-van Holthe JE; Tasic V; Ludwig M
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1430-6. PubMed ID: 18480301
[TBL] [Abstract][Full Text] [Related]
10. Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease.
Wu G; Zhang W; Na T; Jing H; Wu H; Peng JB
Am J Physiol Cell Physiol; 2012 May; 302(10):C1479-91. PubMed ID: 22378746
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria in Dent disease: a review of the literature.
van Berkel Y; Ludwig M; van Wijk JAE; Bökenkamp A
Pediatr Nephrol; 2017 Oct; 32(10):1851-1859. PubMed ID: 27757584
[TBL] [Abstract][Full Text] [Related]
12. Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature:
Gianesello L; Arroyo J; Del Prete D; Priante G; Ceol M; Harris PC; Lieske JC; Anglani F
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680992
[TBL] [Abstract][Full Text] [Related]
13. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
[TBL] [Abstract][Full Text] [Related]
14. IPIP27A cooperates with OCRL to support endocytic traffic in the zebrafish pronephric tubule.
Oltrabella F; Jackson-Crawford A; Yan G; Rixham S; Starborg T; Lowe M
Hum Mol Genet; 2022 Apr; 31(8):1183-1196. PubMed ID: 34673953
[TBL] [Abstract][Full Text] [Related]
15. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
De Matteis MA; Staiano L; Emma F; Devuyst O
Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
[TBL] [Abstract][Full Text] [Related]
16. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome.
Bothwell SP; Farber LW; Hoagland A; Nussbaum RL
Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266
[TBL] [Abstract][Full Text] [Related]
17. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL.
Pirruccello M; De Camilli P
Trends Biochem Sci; 2012 Apr; 37(4):134-43. PubMed ID: 22381590
[TBL] [Abstract][Full Text] [Related]
18. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.
Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM
Mol Autism; 2018; 9():44. PubMed ID: 30147856
[TBL] [Abstract][Full Text] [Related]
19. Novel OCRL mutations in Chinese children with Lowe syndrome.
Zhang YQ; Wang F; Ding J; Yan H; Yang YL
World J Pediatr; 2013 Feb; 9(1):53-7. PubMed ID: 23389333
[TBL] [Abstract][Full Text] [Related]
20. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
